Patent for Enhancing Immunotherapy in Cancer Treatment Granted to Galectin Therapeutics – Nasdaq
|
Patent for Enhancing Immunotherapy in Cancer Treatment Granted to Galectin Therapeutics
Nasdaq Cancer immunotherapy research conducted by Dr. William Redmond at the Earle A. Chiles Research Institute at the Providence Cancer Center in Portland, Oregon was instrumental in the allowance of this patent. Members of Galectin and Providence are joint … |
